Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man who has been diagnosed with prostate cancer
- You have been tested and confirmed to carry a gene mutation that is linked to an increased risk of prostate cancer
- OR you have been tested and confirmed not to carry one of these gene mutations
Who may not be able to join:
- You are under 18 years of age
- You are not able to give your own consent to take part in the study
- You cannot be contacted for follow-up over at least 6 months, or your medical records are not available
- You have not been tested for the relevant gene mutations, so your genetic status is unknown
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rosalind A Eeles, PhD, Institute of Cancer Research, United Kingdom
Phone: 44 208 722 4483
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cause Specific Survival (CSS) will be measured in men with prostate cancer who carry a rare germline mutation and compared to CSS in non-carriers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.